Conferences
EAU 2024: Risk Adapted Screening for Prostate Cancer in Europe: PSA + MRI + Targeted Biopsies Only (Gothenburg-2 Trial)
April 8, 2024
EAU 2024: Risk Adapted Screening for Prostate Cancer in Europe: PSA + MRI (OPT - the Swedish Nationwide Screening Strategy)
April 8, 2024
EAU 2024: PARP-Inhibitors Only for Patients with Alterations in DNA Repair Genes: The Guidelines' View
April 8, 2024
EAU 2024: State-of-the-Art Lecture: Advancements in Cutting-Edge SBRT Therapy for Oligometastatic Kidney Cancer
April 8, 2024